Real-time enrollment status for this locally advanced adrenal cortical carcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:10 PM UTC
| NCT Number | NCT06900595 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced Adrenal Cortical Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 48 participants |
| Active Locations | 81 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | September 18, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT06900595 is currently recruiting participants. This phase2 study for locally advanced adrenal cortical carcinoma is actively seeking new participants at 81 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06900595 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 81 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06900595 was last updated 3 weeks ago (September 18, 2026). HelloStudys verifies this status automatically.